亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

磷酸西他列汀 医学 肾功能 安慰剂 内科学 磷酸西他列汀 肾脏疾病 2型糖尿病 人口 透析 格列吡嗪 胃肠病学 糖尿病 泌尿科 内分泌学 病理 替代医学 环境卫生
作者
Juliana C.N. Chan,Russell Scott,Juan Camilo Arjona Ferreira,Pei Chia Eng,Edward J. Gonzalez,Michael J. Davies,Peter P. Stein,Keith D. Kaufman,John M. Amatruda,Debora Williams‐Herman
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:10 (7): 545-555 被引量:236
标识
DOI:10.1111/j.1463-1326.2008.00914.x
摘要

To assess the safety of sitagliptin in patients with type 2 diabetes and moderate [creatinine clearance (CrCl) > or =30 to <50 ml/min] or severe renal insufficiency [CrCl <30 ml/min including patients with end-stage renal disease (ESRD) on dialysis]. The efficacy of sitagliptin in this patient population was also assessed.In a 54-week, randomized, double-blind, parallel-group study, patients with baseline glycosylated haemoglobin A(1c) (HbA(1c)) values of 6.5-10% were allocated (2:1) to sitagliptin (for 54 weeks) or the sequence of placebo (for 12 weeks) followed by active treatment with glipizide (for 42 weeks). To achieve plasma concentrations similar to those observed in patients with normal renal function treated with 100 mg sitagliptin once daily, patients with moderate renal insufficiency were allocated to receive sitagliptin 50 mg once daily and patients with severe renal insufficiency to receive 25 mg once daily. Glipizide treatment was initiated at 2.5 or 5 mg/day and uptitrated to a maximum of 20 mg/day.Patients (N = 91) with a mean baseline HbA(1c) value of 7.7% (range: 6.2-10.3%) were randomized to sitagliptin (n = 65) or placebo (n = 26). After 12 weeks, the mean change [95% confidence interval (CI)] from baseline in HbA(1c) was -0.6% (-0.8, -0.4) in the sitagliptin group compared with -0.2% (-0.4, 0.1) in the placebo group [between-group difference (95% CI) = -0.4% (-0.7, -0.1)]. At 54 weeks, patients continuously treated with sitagliptin had a mean change (95% CI) from baseline in HbA(1c) of -0.7% (-0.9, -0.4). The overall incidence of adverse experiences was generally similar between groups. Between-group differences in incidences of specific clinical adverse experiences were generally small; however, the proportion of patients for whom hypoglycaemia was reported was lower in the sitagliptin group (4.6%) compared with the placebo/glipizide group (23.1%). Consistent with the high mortality risk in this patient population, there were six deaths during this 54-week study [5 of 65 patients (7.7%) in the sitagliptin group and 1 of 26 patients (3.8%) in the placebo/glipizide group]; no death was considered by the investigator to be drug related. The overall incidences of drug-related and serious adverse experiences and discontinuations because of adverse experiences were generally similar between groups.In this study, sitagliptin was generally well tolerated and provided effective glycaemic control in patients with type 2 diabetes and moderate to severe renal insufficiency, including patients with ESRD on dialysis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
阿金啊发布了新的文献求助30
3秒前
cyy完成签到 ,获得积分10
11秒前
14秒前
15秒前
luang完成签到,获得积分10
17秒前
个性慕青完成签到 ,获得积分10
21秒前
丘丘完成签到,获得积分10
21秒前
RRRZZ完成签到 ,获得积分10
29秒前
习习完成签到,获得积分10
29秒前
所所应助小真白采纳,获得10
30秒前
科研通AI2S应助内向的小脑采纳,获得10
33秒前
mingli的tau发布了新的文献求助10
38秒前
科研通AI5应助LJ_scholar采纳,获得10
41秒前
44秒前
yf完成签到,获得积分10
44秒前
yf发布了新的文献求助10
50秒前
七草肃完成签到,获得积分10
53秒前
Hexagram完成签到 ,获得积分10
54秒前
Jasper应助ceeray23采纳,获得20
54秒前
张牧之完成签到 ,获得积分10
56秒前
哈哈哈大赞完成签到,获得积分10
58秒前
打打应助yf采纳,获得10
1分钟前
1分钟前
YoungJC66发布了新的文献求助10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
李健应助科研通管家采纳,获得10
1分钟前
1分钟前
FashionBoy应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
123完成签到 ,获得积分10
1分钟前
轻松的惜芹应助3719left采纳,获得10
1分钟前
狮子清明尊完成签到,获得积分10
1分钟前
高高烙发布了新的文献求助10
1分钟前
河狸上校完成签到 ,获得积分10
1分钟前
HYQ完成签到 ,获得积分10
1分钟前
1分钟前
木有完成签到 ,获得积分10
1分钟前
3719left完成签到,获得积分10
1分钟前
1分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990012
求助须知:如何正确求助?哪些是违规求助? 3532068
关于积分的说明 11256227
捐赠科研通 3270933
什么是DOI,文献DOI怎么找? 1805123
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809216